Bank of New York Mellon Corp Trims Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Bank of New York Mellon Corp cut its position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 29,214 shares of the company’s stock after selling 428 shares during the quarter. Bank of New York Mellon Corp’s holdings in LENZ Therapeutics were […]
Bank of New York Mellon Corp cut its position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 29,214 shares of the company’s stock after selling 428 shares during the quarter. Bank of New York Mellon Corp’s holdings in LENZ Therapeutics were […]
